<DOC>
	<DOCNO>NCT02213159</DOCNO>
	<brief_summary>The purpose study determine Dexmedetomidine give end surgery reduce postoperative morphine consumption improve postoperative quality recovery compare morphine patient undergo laparoscopic bariatric surgery .</brief_summary>
	<brief_title>Dexmedetomidine Postoperative Analgesia After Bariatric Surgery</brief_title>
	<detailed_description>effect Dexmedetomidine bolus postoperative morphine requirement</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Body Mass Index &gt; 40 kg/m2 BMI &gt; 35 kg/m2 comorbid condition hypertension , diabetes sleep apnea American Society Anesthesiologists class I II Undergoing laparoscopic sleeve gastrectomy bariatric surgery Allergy morphine derivative Allergy Î±2 adrenergic agonist weight 180 kg history uncontrolled hypertension heart block great first degree prolong QT interval clinically significant neurologic , cardiovascular , renal , hepatic , gastrointestinal disease receive opioid analgesic medication within 24 h period prior surgery history alcohol , drug abuse chronic opioid intake history psychiatric disorder pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>postoperative pain</keyword>
	<keyword>morphine consumption</keyword>
	<keyword>Quality recovery</keyword>
</DOC>